Xeris Pharmaceuticals | XERS - Ativo Circulante





Ativo Circulante Alterar Data
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Sartorius EUR 1.72B 449M 2025-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09